Search Options

Show Categories
Show Cities
Show Listing With
Website Email Address

GlaxoSmithKline Consumer Division

GlaxoSmithKline Consumer Division Details
Business Activity/Category:Medical Services & Supplies > Pharmaceutical Products
City:Dubai
Country:United Arab Emirates
Telephone:
  • DXB:04-3319101      (+971 4 3319101) or (043319101)
Fax:
  • DXB:04-3329213      (+971 4 3329213) or (043329213)
P.O.Box:23816
Location:24th Floor, API Tower, Sheikh Zayed Road
Website:

GlaxoSmithKline welcomes the European Commissions new strategy to tackle antibiotic resistance, which commits to help fund a collaborative research and development programme involving industry and public partners. In 1998 GSK formed a partnership with the world health organisation to eliminate LF through the donation of its antiparasitic medicine, albendazole More about our commitment to eliminate lymphatic filariasis These press releases are intended for business journalists and analysts/investors. 05 December 2011 GSK statement in response to the Prime Ministers speech on life sciences 01 December 2011 Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine 01 December 2011 Reporting on a core earnings basis will begin with effect from Q1 2012 Site map | Terms and conditions | Accessibility | Your privacy | Procurement | Social media IW access for GSK employees Updated on Thursday 1 December 2011 20012011 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.

Location Map

24th Floor, API Tower, Sheikh Zayed Road
Dubai
United Arab Emirates

3 Comments

Post a Comment

Post Comment
Emad Ali Syed -

I have 5 years of experience with GlaxoSmithKline Pakistan a Medical Service Executive, I am on visit visa and now immediately available in UAE to work with GSK family here in UAE

MOHAMMAD IRSHAD -

I have worked with GSK in pakistan for 7 years as a MEDDICAL REPRESENTATIVE. i want to join GSK DUBAI

ayesha -

i want to work with GSK consumer as i was working with GSK as a proofreader Arabic- English

Keywords:

worldwide, press, world, select, research, glaxosmithkline, december, united, search, releases, paroxetine, media, london, jump, infanrix, antibiotic, zovirax, zantac, updated, tagamet, super, students, strategy, site, rythmol, republic, report, release, registered, products, price, powder, poligrip, polident, patients, odol, medicine, lymphatic, kingdom, investors, information, home, graduates, flixonase, filariasis, fighting, eumovate, eliminate, development, deadlock, corporate, coreg, commitment, collaboration, clinical, careers, break, beconase, zyban, zofran, zinnat, zinacef, zeffix, zealand, years, working, work, west, wernets, wellvone, wellbutrin, welcomes, website, wales, votrient, volibris, viva, vietnam, veramyst, ventolin, venezuela, varilrix, valtrex, valda, vaccines, vaccine, uzbekistan, uruguay, update, ultra, ultiva, ukraine, tyverb, typherix, tykerb, twinrix, turkey, tums, trobalt, trinidad, trimovate, treximet, tracrium, tool, timentin, thursday, thailand, terms, targon, taiwan, tackle, tabloid, synthol, synflorix, switzerland, sweden, subscribe, submits, study, stock, staxyn, states, statement, stanback, speech, spain, south, sominex, solpadeine, social, slovenia, slovakia, singapore, shumitect, shareholders, share, services, seroxat, serevent, seretide, serbia, sensodyne, scotts, sciences, saudi, salvador, rutinoscorbin, russia, rupafin, rotarix, romania, road, rights, right, rica, ribena, revolade, results, respontin, responsibility, response, resistance, residents, reserved, requip, reports, reporting, relenza, regulatory, register, read, quitters, publications, public, provider, provided, promacta, programme, product, procurement, privacy, priorix, prime, prescription, pregnancy, portugal, poland, piriton, pipeline, philippines, phazyme, peru, pentostam, pediatric, pediarix, paxil, past, partnership, partners, parodontax, parnate, pandemrix, panama, panadol, panadeine, pakistan, page, oxide, otosporin, organisation, official, office, nytol, nyse4391, norway, niquitin, nimbex, nigeria, nicorette, nicoderm, nicaragua, nicabate, news, netherlands, navigation, naramig, myanmar, morocco, moldova, mivacron, mission, minutes, minute, ministers, middlesex, mexico, mepron, menitorix, meningococcal, mejoral, medicines, medacalm, med3, maxinutrition, massengill, maltova, malta, malaysia, malarone, macleans, macedonia, lucozade, lse1400p, lozenge, lovaza, longer, live, lithuania, liskonum, limited, life, libenar, levitra, latvia, lanoxin, lanka, lamictal, lactacyd, laboratory, korea, kong, kinrix, kenya, kazakhstan, journalists, japan, jamaica, jalyn, italy, israel, ireland, ipvhib, iodosan, iodex, involving, investis, intended, integrilin, insto, innopran, industry, indonesia, india, imitrex, imigran, iceland, hycamtin, hungary, horlicks, horizant, hong, honduras, hinds, hibitane, hiberix, herzegovina, hepatyrix, help, health, havrix, guatemala, greece, great, granufink, goodys, germany, georgia, gaviscon, fund, france, fortum, fortaz, formigran, formed, footer, flulaval, fluarix, flovent, flonase, flolan, flixotide, finland, fiberchoice, fendrix, fenbid, feel, feeds, feed, exchange, european, estonia, entereg, england, engerix, emulsion, employees, egypt, effect, ecuador, ecotrin, earnings, dynacirc, dyazide, donation, dominican, digibind, developing, detailed, dermovate, dequadin, denmark, debrox, data, daraprim, czech, cyprus, cutivate, crocin, croatia, country, costa, cortal, corsodyl, corega, core, content, contacts, contact, contac, consumer, conditions, communities, committed, commits, commit, commissions, combodart, combination, colombia, collaborative, collaborations, coldrex, citrucel, cholinex, chlorhexamed, china, chile, charting, chap, cetebe, cervarix, centre, ceftin, candidate, canada, cambodia, business, bulgaria, brentford, breathe, brazil, brands, bosnia, boostrix, boniva, blog, biotene, binaca, bexxar, better, betnovate, best, benlysta, belgium, belarus, begin, beechams, becodisks, beano, basis, bangladesh, bactroban, azerbaijan, avodart, avandia, avandaryl, avandamet, avamys, austria, australia, augmentin, atriance, astriginsol, arzerra, arranon, armenia, arixtra, argentina, argatroban, archive, arabia, aquafresh, antiparasitic, annual, anectine, analystsinvestors, amoxil, amerge, ambirix, altargo, altabax, alli, allergy, algeria, albendazole, albania, africa, advanced, advair, adult, adolescent, additional, adartrel, acwy, accessibility, access, abtei, abreva, http://www.gsk.com/common/img/media/olympics/2012-logo-dual.png, http://www.gsk.com//common/img/logo-gsk.gif, Your privacy, Worldwide map, Working at GSK, What are RSS feeds?, US media and news, US job search, US corporate website, UK job search, The World of GSK, The World of GSK, Terms and conditions, Subscribe to press release RSS feed, Students & graduates US, Students & graduates UK, Social media, Site map, Site map, Responsibility, Research & development, Reports and publications, Reporting on a core earnings basis will begin with effect from Q1 2012, Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine, Read about the collaboration to break deadlock in antibiotic research, Product pipeline, Procurement, Paroxetine and pregnancy, Paroxetine and pediatric and adolescent patients, Paroxetine and adult patients, Our work with communities, Our products, Our mission and strategy, Our commitment to the developing world, Official Laboratory Services Provider to London 2012, More Than Medicine blog, More about our commitment to eliminate lymphatic filariasis, Media centre, Jump to navigation, Jump to footer, Jump to content, IW access for GSK employees, Investors, Information for shareholders, Home, GSK worldwide map, GSK worldwide contacts, GSK worldwide, GSK statement in response to the Prime Ministers speech on life sciences, GSK press releases from the past four years, Fighting LF, Detailed share price and charting tool, Contact us, Collaborations, Clinical Study Register, Careers home page, Careers, Annual Report 2010, Advanced search, Accessibility, About us, 26 Oct: Q3 2011 results, 2010 CR Report, GlaxoSmithKline, Products, GSK worldwide, GSK and London 2012, Fighting lymphatic filariasis, Do more, feel better, live longer, Corporate press releases, Collaboration to break deadlock in antibiotic research, Vaccines, Press release archive, Prescription medicines, For US residents, Consumer brands, Clinical data,